Disc Medicine, Inc. Other Nonoperating Income (Expense)
Disc Medicine, Inc. (IRON) reported Other Nonoperating Income (Expense) of -$12.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-07-30
- Disc Medicine, Inc. other nonoperating income (expense) for the quarter ending 2026-06-30 was -$12.00K, a 117.65% decline year-over-year.
- Disc Medicine, Inc. other nonoperating income (expense) for the quarter ending 2026-03-31 was $22.00K.
- Disc Medicine, Inc. other nonoperating income (expense) for the quarter ending 2025-12-31 was -$2.00K, a 166.67% decline year-over-year.
- Disc Medicine, Inc. other nonoperating income (expense) for the quarter ending 2025-09-30 was -$18.00K, a 300.00% decline year-over-year.
- Disc Medicine, Inc. other nonoperating income (expense) for fiscal 2025 was $45.00K.
- Disc Medicine, Inc. other nonoperating income (expense) for fiscal 2024 was -$2.00K.
- Disc Medicine, Inc. other nonoperating income (expense) for fiscal 2023 was -$2.00K.
- Disc Medicine, Inc. other nonoperating income (expense) for fiscal 2022 was $0.00.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$12.00K 10-Q · filed 2026-07-30 | $10.00K 10-Q · filed 2026-07-30 | $8.00K derived: sum of 3 quarters · filed 2026-07-30 | -$10.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $22.00K 10-Q · filed 2026-05-05 | $20.00K derived: sum of 2 quarters · filed 2026-05-05 | $2.00K derived: sum of 3 quarters · filed 2026-05-05 | $70.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$20.00K derived: sum of 2 quarters · filed 2026-02-26 | $48.00K derived: sum of 3 quarters · filed 2026-07-30 | $45.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | -$18.00K 10-Q · filed 2025-11-06 | $50.00K derived: sum of 2 quarters · filed 2026-07-30 | $47.00K 10-Q · filed 2025-11-06 | $50.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $68.00K 10-Q · filed 2026-07-30 | $65.00K 10-Q · filed 2026-07-30 | $68.00K derived: sum of 3 quarters · filed 2026-07-30 | $77.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$3.00K 10-Q · filed 2026-05-05 | $0.00 derived: sum of 2 quarters · filed 2026-05-05 | $9.00K derived: sum of 3 quarters · filed 2026-05-05 | -$4.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $12.00K derived: sum of 2 quarters · filed 2026-02-26 | -$1.00K derived: sum of 3 quarters · filed 2026-02-26 | -$2.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $9.00K 10-Q · filed 2025-11-06 | -$4.00K derived: sum of 2 quarters · filed 2025-11-06 | -$5.00K 10-Q · filed 2025-11-06 | -$15.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$13.00K 10-Q · filed 2025-08-07 | -$14.00K 10-Q · filed 2025-08-07 | -$24.00K derived: sum of 3 quarters · filed 2026-02-26 | -$11.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$1.00K 10-Q · filed 2025-05-07 | -$11.00K derived: sum of 2 quarters · filed 2026-02-26 | $2.00K derived: sum of 3 quarters · filed 2026-02-26 | -$3.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.00K derived: sum of 2 quarters · filed 2026-02-26 | -$2.00K derived: sum of 3 quarters · filed 2026-02-26 | -$2.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $13.00K 10-Q · filed 2024-11-12 | $8.00K derived: sum of 2 quarters · filed 2024-11-12 | $8.00K 10-Q · filed 2024-11-12 | $8.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$5.00K 10-Q · filed 2024-08-08 | -$5.00K 10-Q · filed 2024-08-08 | -$5.00K derived: sum of 3 quarters · filed 2024-08-08 | -$5.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-05-09 | $0.00 derived: sum of 3 quarters · filed 2024-05-09 | $0.00 derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $0.00 derived: sum of 2 quarters · filed 2024-03-21 | $0.00 derived: sum of 3 quarters · filed 2024-03-21 | $0.00 10-K · filed 2024-03-21 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $3.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-11 | $0.00 10-Q · filed 2023-08-11 | $3.00K derived: sum of 3 quarters · filed 2023-08-11 | $1.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $3.00K 10-Q · filed 2022-05-06 | $3.00K derived: sum of 2 quarters · filed 2022-05-06 | $1.00K derived: sum of 3 quarters · filed 2022-05-06 | -$10.00K derived: sum of 4 quarters · filed 2022-05-06 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$2.00K derived: sum of 2 quarters · filed 2022-03-10 | -$13.00K derived: sum of 3 quarters · filed 2022-03-10 | -$13.00K 10-K · filed 2022-03-10 |
| 2021-09-30 | -$2.00K 10-Q · filed 2021-11-15 | -$13.00K derived: sum of 2 quarters · filed 2021-11-15 | -$13.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$11.00K 10-Q · filed 2021-08-12 | -$11.00K 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |